top of page

Blue November: genetic test aids in prostate cancer fetection and prevention

Men with a family history of prostate cancer can particularly benefit from this test, as it identifies whether an individual has inherited mutations that increase the risk of developing the disease.

Genetic testing is a DNA analysis that can identify mutations and variations in specific genes | Photo: GettyImages


During november, a global campaign focused on men's health, the emphasis on prostate cancer prevention takes center stage. In this initiative, genetic testing stands out as a valuable resource because it helps map predispositions, enabling preventive measures to be taken even before the disease manifests. Geneticist Fernanda Ayala explains that genetic mapping provides valuable information about hereditary predispositions, revealing factors that may contribute to the development of prostate cancer.

The genetic test analyzes DNA and identifies mutations in specific genes that increase the likelihood of certain types of cancer, such as prostate cancer. This type of analysis offers a deep understanding of genetic influences on each individual, allowing for the identification of inherited mutations in genes like BRCA1 and BRCA2, which, although often associated with breast and ovarian cancer, can also be linked to prostate cancer. “When we can map these mutations, we provide patients with the opportunity to take preventive action,” says Fernanda Ayala. ✅ Click and follow Elementary Science on Instagram

Men with a family history of prostate cancer, in particular, can greatly benefit from this test, as it indicates whether the individual has inherited mutations that increase the likelihood of developing the disease. The geneticist points out that those with these mutations have a significantly higher risk of developing prostate cancer. “This type of test goes beyond a simple laboratory analysis; it offers an individualized perspective on the patient’s health, helping to understand their genetic profile with precision, efficiency, and personalization,” explains Ayala.

In addition to identifying hereditary risk, genetic testing offers important guidance to doctors and patients regarding the next steps in health monitoring. With the results in hand, a personalized follow-up plan can be developed, which may include more frequent screening, lifestyle adjustments, and even preventive interventions.

Fernanda Ayala also highlights the value of genetic testing in providing greater peace of mind for patients. By understanding their predispositions, patients can take an active role in their health care, making informed choices that promote quality of life and longevity. For many, this test serves as an incentive to change habits, with the understanding that prevention is within reach.

This Movember, Fernanda Ayala leaves a clear message: genetic testing technology is an essential tool for personalized prevention, especially in the fight against prostate cancer. It is a resource that goes beyond early diagnosis, offering a health approach based on precise genetic data, providing greater security and control over one's health.


bottom of page